Cargando…
The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells
BACKGROUND: MDM2 is a negative regulator of p53 and is upregulated in numerous human cancers. While different MDM2 splice variants have been observed in both normal tissues and malignant cells, their functions are poorly understood. METHODS: We evaluated the effect of MDM2 splice variants by overexp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576977/ https://www.ncbi.nlm.nih.gov/pubmed/28844019 http://dx.doi.org/10.1016/j.tranon.2017.07.006 |
_version_ | 1783260261572935680 |
---|---|
author | Huun, Johanna Gansmo, Liv B. Mannsåker, Bård Iversen, Gjertrud T. Sommerfelt-Pettersen, Jan Øvrebø, Jan Inge Lønning, Per E. Knappskog, Stian |
author_facet | Huun, Johanna Gansmo, Liv B. Mannsåker, Bård Iversen, Gjertrud T. Sommerfelt-Pettersen, Jan Øvrebø, Jan Inge Lønning, Per E. Knappskog, Stian |
author_sort | Huun, Johanna |
collection | PubMed |
description | BACKGROUND: MDM2 is a negative regulator of p53 and is upregulated in numerous human cancers. While different MDM2 splice variants have been observed in both normal tissues and malignant cells, their functions are poorly understood. METHODS: We evaluated the effect of MDM2 splice variants by overexpression in MCF-7 cells and analyses of expression of downstream genes (qPCR and Western blot), subcellular localization (immunofluorescence), cell cycle assays (Nucleocounter3000), apoptosis analysis (Annexin V detection), and induction of senescence (β-galactosidase analysis). RESULTS: In a screen for MDM2 splice variants in MCF-7 breast cancer cells, extended with data from healthy leukocytes, we found P2-MDM2-10 and MDM2-Δ5 to be the splice variants expressed at highest levels. Contrasting MDM2 full-length protein, we found normal tissue expression levels of P2-MDM2-10 and MDM2-Δ5 to be highest in individuals harboring the promoter SNP309TT genotype. While we detected no protein product coded for by MDM2-Δ5, the P2-MDM2-10 variant generated a protein markedly more stable than MDM2-FL. Both splice variants were significantly upregulated in stressed cells (P = 4.3 × 10(−4) and P = 7.1 × 10(−4), respectively). Notably, chemotherapy treatment and overexpression of P2-MDM2-10 or MDM2-Δ5 both lead to increased mRNA levels of the endogenous MDM2-FL (P = .039 and P = .070, respectively) but also the proapoptotic gene PUMA (P = .010 and P = .033, respectively), accompanied by induction of apoptosis and repression of senescence. CONCLUSION: We found P2-MDM2-10 and MDM2-Δ5 to have distinct biological functions in breast cancer cells. GENERAL SIGNIFICANCE: Alternative splicing may influence the oncogenic effects of the MDM2 gene. |
format | Online Article Text |
id | pubmed-5576977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Neoplasia Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55769772017-09-06 The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells Huun, Johanna Gansmo, Liv B. Mannsåker, Bård Iversen, Gjertrud T. Sommerfelt-Pettersen, Jan Øvrebø, Jan Inge Lønning, Per E. Knappskog, Stian Transl Oncol Original article BACKGROUND: MDM2 is a negative regulator of p53 and is upregulated in numerous human cancers. While different MDM2 splice variants have been observed in both normal tissues and malignant cells, their functions are poorly understood. METHODS: We evaluated the effect of MDM2 splice variants by overexpression in MCF-7 cells and analyses of expression of downstream genes (qPCR and Western blot), subcellular localization (immunofluorescence), cell cycle assays (Nucleocounter3000), apoptosis analysis (Annexin V detection), and induction of senescence (β-galactosidase analysis). RESULTS: In a screen for MDM2 splice variants in MCF-7 breast cancer cells, extended with data from healthy leukocytes, we found P2-MDM2-10 and MDM2-Δ5 to be the splice variants expressed at highest levels. Contrasting MDM2 full-length protein, we found normal tissue expression levels of P2-MDM2-10 and MDM2-Δ5 to be highest in individuals harboring the promoter SNP309TT genotype. While we detected no protein product coded for by MDM2-Δ5, the P2-MDM2-10 variant generated a protein markedly more stable than MDM2-FL. Both splice variants were significantly upregulated in stressed cells (P = 4.3 × 10(−4) and P = 7.1 × 10(−4), respectively). Notably, chemotherapy treatment and overexpression of P2-MDM2-10 or MDM2-Δ5 both lead to increased mRNA levels of the endogenous MDM2-FL (P = .039 and P = .070, respectively) but also the proapoptotic gene PUMA (P = .010 and P = .033, respectively), accompanied by induction of apoptosis and repression of senescence. CONCLUSION: We found P2-MDM2-10 and MDM2-Δ5 to have distinct biological functions in breast cancer cells. GENERAL SIGNIFICANCE: Alternative splicing may influence the oncogenic effects of the MDM2 gene. Neoplasia Press 2017-08-29 /pmc/articles/PMC5576977/ /pubmed/28844019 http://dx.doi.org/10.1016/j.tranon.2017.07.006 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original article Huun, Johanna Gansmo, Liv B. Mannsåker, Bård Iversen, Gjertrud T. Sommerfelt-Pettersen, Jan Øvrebø, Jan Inge Lønning, Per E. Knappskog, Stian The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells |
title | The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells |
title_full | The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells |
title_fullStr | The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells |
title_full_unstemmed | The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells |
title_short | The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells |
title_sort | functional roles of the mdm2 splice variants p2-mdm2-10 and mdm2-∆5 in breast cancer cells |
topic | Original article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576977/ https://www.ncbi.nlm.nih.gov/pubmed/28844019 http://dx.doi.org/10.1016/j.tranon.2017.07.006 |
work_keys_str_mv | AT huunjohanna thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT gansmolivb thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT mannsakerbard thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT iversengjertrudt thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT sommerfeltpettersenjan thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT øvrebøjaninge thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT lønningpere thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT knappskogstian thefunctionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT huunjohanna functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT gansmolivb functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT mannsakerbard functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT iversengjertrudt functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT sommerfeltpettersenjan functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT øvrebøjaninge functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT lønningpere functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells AT knappskogstian functionalrolesofthemdm2splicevariantsp2mdm210andmdm25inbreastcancercells |